4  5  6
  • Basic Info
Licensed from
Generic: Dicalcium phosphate
treats Laxative/bowel preparation for procedures, Burns, Exercise performance, Hypercalcemia, Bone density, Total parenteral nutrition, Refeeding syndrome prevention, Vitamin D resistant rickets, Kidney stones, Diabetic ketoacidosis, Hyperparathyroidism, Constipation, Hypercalciuria, and Hypophosphatemia

To get info about second drug, type a name above.


DISCLAIMER: Natural Standard developed the above evidence- based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to Selected references are listed below.

Block GA, Hulbert- Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31(4):607- 617.

Bredle DL, Stager JM, Brechue WF, et al. Phosphate supplementation, cardiovascular function, and exercise performance in humans. J Appl Physiol 1988;65(4):1821- 1826.

Bugg NC, Jones JA. Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 1998;53(9):895- 902.

Ehrenpreis ED, Nogueras JJ, Botoman VA, et al. Serum electrolyte abnormalities secondary to Fleet's Phospho- Soda colonoscopy prep. A review of three cases. Surg Endosc 1996;10(10):1022- 1024.

Fakiris AJ, Moore DH, Reddy SR, et al. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97- 01) study. Gynecol Oncol 2005;96(3):818- 823.

Fine A, Patterson J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis. 1997;29(1):103- 105.

Finn WF, Joy MS. A long- term, open- label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis. Curr Med Res Opin. 2005;21(5):657- 664.

Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J.Clin.Endocrinol.Metab 1983;57(1):177- 180.

Garg JP, Chasan- Taber S, Blair A, et al. Effects of sevelamer and calcium- based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial. Arthritis Rheum 2005;52(1):290- 295.

Heaney RP, Nordin BE. Calcium effects on phosphorus absorption: implications for the prevention and co- therapy of osteoporosis. J Am Coll Nutr 2002;21(3):239- 244.

Helikson MA, Parham WA, Tobias JD. Hypocalcemia and hyperphosphatemia after phosphate enema use in a child. J Pediatr Surg 1997;32(8):1244- 1246.

Kastenberg D, Chasen R, Choudhary C, et al. Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multicenter phase III trials. Gastrointest Endosc 2001;54(6):705- 713.

Kemi VE, Kärkkäinen MU, Lamberg- Allardt CJ. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose- dependent manner in healthy young females. Br J Nutr. 2006 Sep;96(3):545- 52.

Kurihara S, Tsuruta Y, Akizawa T. Effect of MCI- 196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double- blind, placebo- controlled, short- term trial. Nephrol Dial Transplant 2005;20(2):424- 430.

National Research Council, Food and Nutrition Board. Recommended Dietary Allowances. 10th ed. Washington, D.C.: National Academy Press; 1989:184- 187.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

 4  5  6